Deep Dive #1: AI-Enabled Drug Discovery
BIOS: Nucleus of Life Science Innovation 🚀
JOBS
BIOS Talent: Find Jobs @ Breakout TechBio Startups  —  Search Jobs 🚀
Post Jobs: Add Your Startup to BIOS Talent  —  Post Now 🎉
Students: Join Alix Ventures Fellowship  —  Join Now 🧬
BIOS Contributor: Share Your Thought Leadership  —  Join Now🔬
CONTENT & COMMUNITY
BIOS Daily: Join 25K+ Subscribers Following TechBio  —  Sign Up 🔥
BIOS Insider: Premium TechBio Thought Leadership  —  Sign Up ✨
BIOS Commons: World’s Largest #TechBio Community  —  Join Now 🎉
INVEST
BIOS Angels: 1st TechBio Angel Investing Syndicate  —  Join Now 🌟
Alix Limited: Invest in Breakout TechBio Startups  —  Learn More ðŸ§
By:
Alix Ventures: Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human Health
Intro
It’s no secret that the traditional drug discovery model is expensive, time consuming, and has recently produced compounds with marginal efficacy in clinical trials and high failure rates. Large biopharma companies are increasingly outsourcing R&D to academic labs and small/mid size startups via licensing partnerships or acquisitions. Biopharma is among the most active industry sectors in terms of mergers and acquisitions and this trend looks to grow as companies stockpile more and more cash. This is all evidence to demonstrate that large cap biopharma companies have yet to create efficient internal R&D programs and thus have a need for high efficiency screening and discovery programs.